亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Cerebral vessels during chronic hypertension: from arteries to therapeutics

作者
Jean‐Marc Chillon
出处
期刊:Journal of Hypertension [Lippincott Williams & Wilkins]
卷期号:20 (5): 817-818 被引量:2
标识
DOI:10.1097/00004872-200205000-00007
摘要

In this issue of the journal, Kitazono et al. examined the factors which play a role in the regulation of the basal tone of the basilar artery in spontaneously hypertensive rats (SHR) in vivo [1]. The choice of a large diameter vessel, such as the basilar artery (approximately 200 μm), to study cerebrovascular resistance may initially be surprising. However, it should be noted that, for the cerebral circulation, large diameter intracranial vessels contribute to approximately one-half of the cerebrovascular resistance [2]. As stated by the authors, chronic hypertension is associated with alterations of cerebral arteries leading to an increase in their resistance. The authors considered only ‘functional’ alteration (i.e. enhanced vasoconstriction and impaired vasorelaxation). However, structural alterations may also contribute to the increase in cerebrovascular resistance. For example, hypertrophy of the vessel wall with encroachment on the vascular lumen [3] and/or vascular remodelling (defined as a reduction in external diameter of the vessels that cannot be accounted for by a reduction in vascular distensibility) [4] may increase the resistance of small cerebral arterioles in spontaneously hypertensive rats [5]. In larger cerebral arteries, such as large branches of posterior cerebral arteries, a reduction in vessel wall passive distensibility apparently impairs the maximal dilator capacity and increases resistance [6]. Considering the functional alterations, the results presented by Kitazono et al. show that increased contractility but not reduced dilatory capacity may contribute to the increased resistance of the basilar artery of SHR in vivo [1]. This phrase may be somewhat misleading as Kitazono et al. [1] and others [7–9] have shown that endothelium-dependent relaxation is impaired during chronic hypertension. However, as shown by Kitazono et al. for the basilar artery, although agonist-induced release of NO is impaired during chronic hypertension, basal release of NO appears preserved. If increased contractility is considered to contribute to the increase in resistance in the basilar artery of SHR in vivo, several factors may play a role: (i) an increase in the availability of primary messengers; (ii) an increase in the activity and/or the numbers of the membrane reconnaissance and information transformation systems (receptors, ion channels, etc.); and (iii) an activation of the intracellular signal coupling mechanisms. The experiments performed by Kitazono et al. highlight the two latest factors. Indeed, vasorelaxation induced by nicardipine is greater in the basilar artery of SHR compared to that of normotensive Wistar–Kyoto (WKY) rats, suggesting an increased activity or density of L-type calcium channels in vivo as has already been reported in vitro. This activation at the membrane level is accompanied by activation at the intracellular level with an apparent increase of the calcium sensitivity of myofilaments by Rho-associated kinase in the basilar artery of SHR. The absence of change in serotonin-induced constriction is surprising. As stated by Kitazono et al., an increased activity of L-type calcium channels and Rho-associated kinase should enhance agonist-induced contraction. Furthermore, such an increase is observed in vitro. However, to conclude that agonist-induced contraction is not enhanced in the basilar artery of SHR in vivo is somewhat exaggerated. More experiments with other agonists may throw a different light on this problem. It is interesting to speculate on the impact of these findings on the cerebral circulation, especially on cerebral blood flow autoregulation in hypertensive subjects. Indeed, one of the consequences of the increase in cerebrovascular resistance during chronic hypertension is a shift of the cerebral blood flow autoregulatory plateau towards a higher blood pressure level. This allows cerebral blood flow to remain normal despite levels of pressure that, acutely, would produce disruption of the blood–brain barrier and brain damage [10]. It is easy to imagine that the enhanced vasoconstriction in SHR increases cerebrovascular resistance and allows cerebral blood flow to remain constant. Similarly, as the basilar artery is more constricted in SHR than in WKY rats, it may be more able to resist acute increases in pressure. It is somewhat more difficult to envisage the impact on the lower limit of cerebral blood flow autoregulation. Cerebral arteries and arterioles dilate with a decrease in pressure to maintain cerebral blood flow. As basilar arteries are more constricted in SHR than in WKY rats, the vasodilatory reserve should be increased and the lower limit of cerebral blood flow autoregulation decreased, as observed when a cerebral vasoconstrictor is acutely administered to normotensive rats [11,12]. However, an increase and not a decrease of the lower limit of cerebral blood flow autoregulation is observed during chronic hypertension [13]. This suggests that global vasodilatory capacity is not uniquely dependent on the state of vasoconstriction. Finally, as far as the cerebral circulation is concerned, is there any advantage to treating hypertensive subjects with a calcium entry blocker or a Rho-associated kinase antagonist? To decrease blood pressure in hypertensive patients is not sufficient. It is also necessary to decrease resistance, including cerebral resistance. Considering this and the present study by Kitazono et al. [1], a calcium entry blocker may prove to be a good choice for decreasing blood pressure and vascular resistance at least in the basilar artery. However, care has to be taken when using calcium entry blockers. Although one study has shown that the calcium antagonist nimodipine preserves cerebral blood flow autoregulation [14], others have shown exactly the opposite effect [15–17] and calcium entry blockers may also create a steal effect [18]. The same questions would necessarily arise for Rho-associated kinase inhibitors if such products were available for the treatment of hypertension. Acknowledgement I thank Professor J. Atkinson for help in the elaboration and critical review of this commentary.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
贪玩千儿完成签到,获得积分10
刚刚
6秒前
魔幻的松思完成签到,获得积分10
11秒前
冷艳千柳完成签到,获得积分10
25秒前
34秒前
感性的念之完成签到,获得积分10
53秒前
1分钟前
1分钟前
坚定百褶裙完成签到,获得积分10
1分钟前
1分钟前
漂亮的幻枫完成签到,获得积分10
1分钟前
Crisp完成签到 ,获得积分0
1分钟前
枕月完成签到,获得积分10
1分钟前
精明凝海发布了新的文献求助10
1分钟前
悲凉的丝完成签到,获得积分10
2分钟前
2分钟前
饱满飞绿完成签到,获得积分10
2分钟前
ajing发布了新的文献求助10
2分钟前
朴实水云完成签到,获得积分10
2分钟前
2分钟前
2分钟前
枕月发布了新的文献求助10
2分钟前
生动的依白完成签到,获得积分10
3分钟前
AnYX完成签到 ,获得积分10
3分钟前
震动的醉蓝完成签到,获得积分10
3分钟前
3分钟前
Prof.Z发布了新的文献求助80
3分钟前
3分钟前
忧心的棒球完成签到,获得积分10
3分钟前
3分钟前
万霖完成签到,获得积分10
3分钟前
3分钟前
曾经凌萱发布了新的文献求助10
4分钟前
愉快的书桃完成签到,获得积分10
4分钟前
4分钟前
4分钟前
4分钟前
香蕉觅云的应助被曾经凌萱采纳,获得10
4分钟前
慢读文献完成签到,获得积分10
4分钟前
yuxia完成签到 ,获得积分10
4分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8179896
求助须知:如何正确求助?哪些是违规求助? 9570103
关于积分的说明 21808343
捐赠科研通 7775692
什么是DOI,文献DOI怎么找? 3433193
关于科研通互助平台的介绍 2557334
邀请新用户注册赠送积分活动 2478881